Enterprise Value
$478.92 M
-$10.33 M-2.11%
Fri, 07 Feb 2025 21:03:20 GMT
Summary
- As of February 8, 2025, TBPH enterprise value is $478.92 million, with a fall of -$10.33 million (-2.11%) during the most recent trading day.
- TBPH enterprise value is now -79.83% below its all-time high of $2.37 billion.
Performance
TBPH Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
TBPH Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -2.1% | -2.2% | -2.2% |
| 1 m1 month | +0.5% | +0.5% | +0.5% |
| 3 m3 months | - | +6.3% | +6.3% |
| 6 m6 months | - | +19.4% | +18.8% |
| ytdytd | -1.1% | -1.2% | -1.2% |
| 1 y1 year | - | +11.9% | +9.4% |
| 5 y5 years | -78.2% | -73.8% | -69.7% |
TBPH Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -10.7% | $437 M | +9.7% | |
| 3 m | 3-month | $536 M | -10.7% | $437 M | +9.7% |
| 6 m | 6-month | $536 M | -10.7% | $378 M | +26.9% |
| 1 y | 1-year | $536 M | -10.7% | $378 M | +26.9% |
| 3 y | 3-year | $1.38 B | -65.2% | $283 M | +69.3% |
| 5 y | 5-year | $2.26 B | -78.8% | $283 M | +69.3% |
| alltime | all time | $2.37 B | -79.8% | $246 M | +94.8% |
Theravance Biopharma Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $478.92 M(-1.1%) |
| 2024 | $484.33 M(+2.7%) |
| 2022 | $471.49 M(-66.4%) |
| 2021 | $1.40 B(-19.3%) |
| 2020 | $1.74 B(-9.9%) |
| Date | Value |
|---|---|
| 2019 | $1.93 B(+28.5%) |
| 2018 | $1.50 B(-9.1%) |
| 2017 | $1.65 B(+5.7%) |
| 2016 | $1.56 B(+206.4%) |
| 2015 | $509.80 M(+30.2%) |
| 2014 | $391.52 M |
FAQ
- What is Theravance Biopharma enterprise value?
- What is the all time high enterprise value for Theravance Biopharma?
- What is TBPH enterprise value year-to-date change?
What is Theravance Biopharma enterprise value?
The current enterprise value of TBPH is $478.92 M
What is the all time high enterprise value for Theravance Biopharma?
Theravance Biopharma all-time high enterprise value is $2.37 B
What is TBPH enterprise value year-to-date change?
Theravance Biopharma enterprise value has changed by -$5.41 M (-1.12%) since the beginning of the year